Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Adly Yacoub

Showing results (1-10 of 80) with videos related to

Pageof 8
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 10, 2004
Ionizing radiation causes a dose-dependent release of transforming growth factor alpha in vitro from irradiated xenografts and during palliative treatment of hormone-refractory prostate carcinomaMichael Hagan, Adly Yacoub, Paul Dent
Cancer Biology & Therapy|June 23, 2005
DMC: novel celecoxib derivatives to rap cancerPaul Dent, Adly Yacoub, Steven Grant
Journal of Cellular Biochemistry|February 14, 2007
Radiation-induced PARP activation is enhanced through EGFR-ERK signalingMichael P Hagan, Adly Yacoub, Paul Dent
Molecular Pharmacology|August 11, 2010
Poly(ADP-ribose) polymerase 1 modulates the lethality of CHK1 inhibitors in carcinoma cellsClint Mitchell, Margaret Park, Patrick Eulitt, et al.
Journal of Cellular Biochemistry|May 10, 2005
MDA-7/IL-24 regulates proliferation, invasion and tumor cell radiosensitivity: a new cancer therapy?Paul Dent, Adly Yacoub, Steven Grant, et al.
Oncogene|August 30, 2003
MAPK pathways in radiation responsesPaul Dent, Adly Yacoub, Paul B Fisher, et al.
Radiation Research|March 20, 2003
Epidermal growth factor and ionizing radiation up-regulate the DNA repair genes XRCC1 and ERCC1 in DU145 and LNCaP prostate carcinoma through MAPK signalingAdly Yacoub, Robert McKinstry, Darin Hinman, et al.
Molecular Interventions|May 5, 2011
CHK1 inhibitors in combination chemotherapy: thinking beyond the cell cyclePaul Dent, Yong Tang, Adly Yacoub, et al.
Journal of Neurotrauma|September 13, 2013
Neuroprotective effects of perflurocarbon (oxycyte) after contusive spinal cord injuryAdly Yacoub, Marygrace C Hajec, Richard Stanger, et al.
Cancer Biology & Therapy|March 13, 2012
Sorafenib and HDAC inhibitors synergize to kill CNS tumor cellsYong Tang, Adly Yacoub, Hossein A Hamed, et al.
Pageof 8

Showing results (1-10 of 80) with videos related to

Sort By:
Pageof 8
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 10, 2004
Ionizing radiation causes a dose-dependent release of transforming growth factor alpha in vitro from irradiated xenografts and during palliative treatment of hormone-refractory prostate carcinomaMichael Hagan, Adly Yacoub, Paul Dent
Cancer Biology & Therapy|June 23, 2005
DMC: novel celecoxib derivatives to rap cancerPaul Dent, Adly Yacoub, Steven Grant
Journal of Cellular Biochemistry|February 14, 2007
Radiation-induced PARP activation is enhanced through EGFR-ERK signalingMichael P Hagan, Adly Yacoub, Paul Dent
Molecular Pharmacology|August 11, 2010
Poly(ADP-ribose) polymerase 1 modulates the lethality of CHK1 inhibitors in carcinoma cellsClint Mitchell, Margaret Park, Patrick Eulitt, et al.
Journal of Cellular Biochemistry|May 10, 2005
MDA-7/IL-24 regulates proliferation, invasion and tumor cell radiosensitivity: a new cancer therapy?Paul Dent, Adly Yacoub, Steven Grant, et al.
Oncogene|August 30, 2003
MAPK pathways in radiation responsesPaul Dent, Adly Yacoub, Paul B Fisher, et al.
Radiation Research|March 20, 2003
Epidermal growth factor and ionizing radiation up-regulate the DNA repair genes XRCC1 and ERCC1 in DU145 and LNCaP prostate carcinoma through MAPK signalingAdly Yacoub, Robert McKinstry, Darin Hinman, et al.
Molecular Interventions|May 5, 2011
CHK1 inhibitors in combination chemotherapy: thinking beyond the cell cyclePaul Dent, Yong Tang, Adly Yacoub, et al.
Journal of Neurotrauma|September 13, 2013
Neuroprotective effects of perflurocarbon (oxycyte) after contusive spinal cord injuryAdly Yacoub, Marygrace C Hajec, Richard Stanger, et al.
Cancer Biology & Therapy|March 13, 2012
Sorafenib and HDAC inhibitors synergize to kill CNS tumor cellsYong Tang, Adly Yacoub, Hossein A Hamed, et al.
Pageof 8